Locate Bio | John von Benecke showcases Locate’s products

30th March, 2022

Mercia TV catches up with Locate Bio‘s CEO, John von Benecke in its Nottingham laboratory.

John talks through both its lead product LD Graft, a low dose, controlled release, rhBMP-2 bone graft, and CognitOss, an antibiotic loaded bone graft, with a dual and responsive release, for the treatment of osteomyelitis.

Read more on Mercia’s latest investment here